Rivastigmine for Lewy Body Dementia User Reviews
Brand names: Exelon
- Tod...
- Taken for 2 to 5 years
- October 2, 2024
"I've been on rivastigmine for over 2 years now. Started at 1.5 mg twice daily and moved up to 3 mg. I will call this a game changer for me. I am currently 60 and have Lewy Body Dementia, which caused cognitive decline/fluctuations, short-term memory issues, and hallucinations. Rivastigmine has improved my quality of life dramatically. I personally have had no side effects, unlike what donepezil did to me... very serious gastric issues."
- Sue...
- Taken for less than 1 month
- March 31, 2019
"I have been taking 1.5 mg rivastigmine for five days. I feel numb all over, headache, no appetite, and hard to function."
Frequently asked questions
See also:
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
Learn more about Lewy Body Dementia
Care guides
More about rivastigmine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (39)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: cholinesterase inhibitors
Patient resources
- Rivastigmine drug information
- Rivastigmine transdermal
- Rivastigmine (Oral) (Advanced Reading)
- Rivastigmine (Transdermal) (Advanced Reading)
"My doctor in Latin America recommended Rivastigmine Transdermal System, 4.6 mg/24 hours. I had a slight headache on the first day, nothing on the second day. I feel more alert and have a positive disposition. After 2 months of daily use, I have not felt depressed. My daughters say that my mood has changed, that I do not get upset as easily, and seem to have more energy. The cost of the medicine in Latin America was about $30.00 for a three-month supply. In NJ, with insurance, about $195.00. The price difference is difficult to understand."